Cargando…

Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT

BACKGROUND: Recruitment and retention of participants in clinical trials for Parkinson’s disease (PD) is challenging. A qualitative study embedded in the PD STAT multi-centre randomised controlled trial of simvastatin for neuroprotection in PD explored the motivators, barriers and challenges of part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kehagia, Angie A., North, Tracie K., Grose, Jane, Jeffery, Alison N., Cocking, Laura, Chapman, Rebecca, Carroll, Camille
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398073/ https://www.ncbi.nlm.nih.gov/pubmed/35466952 http://dx.doi.org/10.3233/JPD-212987

Ejemplares similares

Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT
por: Day, Jacob O., et al.
Publicado: (2022)

Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience
por: Dominey, Thea, et al.
Publicado: (2020)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial
por: Stevens, Kara N., et al.
Publicado: (2022)

Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis
por: Kehagia, Angie A., et al.
Publicado: (2012)

Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease
por: Creanor, Siobhan, et al.
Publicado: (2015)

Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
por: Carroll, Camille B, et al.
Publicado: (2019)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

Advances in intranasal vaccine delivery: A promising non-invasive route of immunization
por: Kehagia, Eleni, et al.
Publicado: (2023)

Fitness-to-practice concerns in rural undergraduate medical education: a qualitative study
por: Snow, Pamela Claire, et al.
Publicado: (2014)

Realising stratified psychiatry using multidimensional signatures and trajectories
por: Joyce, Dan W., et al.
Publicado: (2017)

From homeostasis to behavior: Balanced activity in an exploration of embodied dynamic environmental-neural interaction
por: Hellyer, Peter John, et al.
Publicado: (2017)

People with Parkinson's design clinical trials charter to improve communication about, recruitment to and retention in Parkinson's clinical trials
por: Stamford, Jon, et al.
Publicado: (2015)

Fatigue and Muscle Strength Involving Walking Speed in Parkinson's Disease: Insights for Developing Rehabilitation Strategy for PD
por: Huang, Ying-Zu, et al.
Publicado: (2017)

Silencing of STAT3 via Peptidomimetic LNP-Mediated Systemic Delivery of RNAi Downregulates PD-L1 and Inhibits Melanoma Growth
por: Ehexige, Ehexige, et al.
Publicado: (2020)

Variable Effects of Autophagy Induction by Trehalose on Herpesviruses Depending on Conditions of Infection
por: Meier, Jeffery L., et al.
Publicado: (2017)

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

Parkinson Disease: PD Gene and Oxidative Stress
por: Phillips, Melissa Lee
Publicado: (2006)

Introduction to Parkinson disease (PD) and its complications
por: Marvanova, Marketa
Publicado: (2016)

The Potential Role of Astrocytes in Parkinson’s Disease (PD)
por: Hindeya Gebreyesus, Hiluf, et al.
Publicado: (2020)

Self-management Interventions for People With Parkinson Disease: Scoping Review
por: Milne-Ives, Madison, et al.
Publicado: (2022)

PD-1/PD-L Axis in Neuroinflammation: New Insights
por: Manenti, Susanna, et al.
Publicado: (2022)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
por: Schrag, A, et al.
Publicado: (2022)

In reply to: Helmich and Bloem (2020) “The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities”
por: Edwards, Emma, et al.
Publicado: (2020)

Insight into 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced disruption of zebrafish spermatogenesis via single cell RNA-seq
por: Haimbaugh, Alex, et al.
Publicado: (2022)

How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme
por: Powell, Alison, et al.
Publicado: (2022)

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
por: Gonzalez-Robles, Cristina, et al.
Publicado: (2023)

A Qualitative Study on the Impact of First Steps—A Peer-led Educational Intervention for People Newly Diagnosed with Parkinson’s Disease
por: Soundy, Andrew, et al.
Publicado: (2019)

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022)

Smelling Parkinson’s Disease: New Metabolomic Biomarker for PD
por: Poewe, Werner
Publicado: (2019)

Brainstem Evoked Potentials in the Idiopathic Parkinson's Disease (PD)
por: Vats, Ajay Kumar
Publicado: (2021)

Targets for astrocyte-based treatments of Parkinson’s disease (PD)
por: Parmar, Malin
Publicado: (2022)

Autophagy Quantification and STAT3 Expression in a Human Skin Organ Culture Model for Innate Immunity to Herpes Zoster
por: Buckingham, Erin M., et al.
Publicado: (2018)

Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls
por: Dagay, Andrew, et al.
Publicado: (2023)

The Use of Descriptive Words and Metaphor in Patient and Carer Experience of Palliative Day Care: Secondary Analysis of a Qualitative Study
por: Richardson, J, et al.
Publicado: (2009)

Microbubble protein delivery for Parkinson’s
por: Keenan, James, et al.
Publicado: (2015)

Critical Care Delivery in India: Stats, State(s) and Strategies
por: Ramakrishnan, Adarsh, et al.
Publicado: (2023)

Subcortical Volumes Differ in Parkinson’s Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms
por: Rosenberg-Katz, Keren, et al.
Publicado: (2016)

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
por: Williams‐Gray, Caroline H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ahiqhcvfl87j3jarhu13rqqkal